HIV and cancer are diseases that do not go away on their own while COVID19 does, so it is not a good comparison. Also, now COVID19 is a global pandemic that is easily transmissible and kills an individual in a short period of time. Majority of the pharma/biotech firm are currently concentrating their effort to resolve this. Compare that to the number of firms working to research cancer or HIV cures.
Its a very good comparison because Covid-19 has not proven it can go away on its own. It's still new and researchers are still learning about it. Hopefully by the end of the year they'll know how much intervention / control is needed to manage it. Other than that, when was the last time you compared the money put into Cancer or HIV in comparison to Covid-19 ??? By end of year, a lot of answers will be found and too many people think 100s of firms going different ways will magically resolve the situation. Then there's the "mutation" factor...ooops. wrbtrader
COVID19 patients get discharged when they are tested and do not have any virus in their system (at least outside USA). So yes it does go away by itself. BTW it is not the dollar amount thrown into research that determines success but the number of heads being put together concurrently and working at different angles.
Well...if you want to count people that go to the hospital for an illness and then get treated for that illness and then they recover as...someone with an illness that goes away on its on... Then you're right. Look, there are people that get sick and do not get treated, do not go to a hospital nor seek any medical attention from anyone... They beat Covid-19. So yeah, in those situations...those people that had Covid-19 are obviously better off than those that had Cancer or HIV that then had no medical treatment. The dollar amount is critically important because researchers like to get paid plus they like to get recognize for their research efforts that at the end of the day do in fact attract money in the form of contracts, donations, endowments, awards and such. Simply, its a silly debate or useless debate to talk about which is more important...number of researchers versus amount of dollars. wrbtrader
Yeah, they want to get paid too at some point in their research especially when many in the world are dying, getting sick, losing jobs, losing businesses and such. Scary situation to be working for free. wrbtrader
My point is that this disease is more curable than cancer and HIV. We all want life to return back to normal as soon as possible.
Apparently, the company is pretty young and sketchy, no drug ever brought to the markets. My bet is on showing only the positive results. https://www.marketwatch.com/story/m...ter-covid-19-vaccine-study-success-2020-05-18 "Trumps Vaccine Czar - Dr. Moncef Slaoui - is a past member of MRNA's board of directors and has 150,000 stock options that can be exercised/sold after 4/29/2020 with a cost basis of $46.37. At today's price of $78 that equates to a payday of $4,744,500.00 just today alone."
The reason schools are shut down is two fold. One to protect the kids, and two, to protect the adults, particularly the adults in the kids homes. It not who get it that matters it is how many on average each infected person passes the virus to. The reason for isolation is to bring that number below one. In the U.S. we've chosen this "isolation" approach to bringing the pandemic under control because we lack the adequate testing and tracking. We are still behind other countries in testing and tracking. Trump says, "we are doing more testing than anyone." He doesn't know what "per capita" means.